Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Braxia Scientific Corp C.BRAX

Alternate Symbol(s):  BRAXF

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.


CSE:BRAX - Post by User

Comment by cautiousguyon Aug 08, 2020 12:16am
305 Views
Post# 31382070

RE:RE:RE:RE:RE:RE:RE:Just a thought about the HALT.

RE:RE:RE:RE:RE:RE:RE:Just a thought about the HALT.OriginalG,Since you seem raised this issue and seem interested in continuing this dissussion I will respond. 
 
Dr. Roger McIntyre
Chief Executive Officer
E: info@champignonbrands.com 

When you go to the Champignon website and hover the mouse over the email address shown above, on the bottom left hand corner of the screen you will see the following   mailto:info@whateveroururlis  I have written to the email above several times and have received no response.  As a result, I am unsure is that email is functional.  

However, the Investor Inquiry email address shown below has responded to some questions.

I have attempted to write to Dr. McIntyre through both addresses as well other addresses shown on searches of the internet.  None of these have been responded to in any form.

FOR INVESTOR INQUIRIES: 
Champignon Brands | Storyboard Communications
Investor Relations, Toronto, Canada
Investor Line: +1 (833) 375-9995 x611
E: champignonbrands@storyboardcommunications.com

I have attempted to write to Dr. McIntyre through both addresses as well other addresses shown on searches of the internet.  None of these have been responded to in any form.

All of this of course highlights my observations that I have previously drawn attention  to on this site.  These are the same comments that are referred to by some as bashing.

Unless you want to have the last word, I am ready to end this conversation now.



<< Previous
Bullboard Posts
Next >>